MedPath

A prospective randomized study on the incidence of postoperative Proximal junctional fracture(PJF) in patients undergoing spinal deformity surgery according to osteoporosis drugs

Not Applicable
Recruiting
Conditions
Adult spinal deformity surgery
Registration Number
JPRN-UMIN000044337
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with neuromuscular diseases such as Parkinson's disease 2. Patients with syndromic scoliosis 3. Patients who have undergone surgery for spinal deformity due to infection or tumor. 4. Patients who are deemed inappropriate by the doctor in charge. 5. women who are pregnant or who wish to become pregnant 6. Patients who have already been treated with teriparatide for osteoporosis 7.Patients for whom teriparatide is contraindicated (Paget's disease of bone, unexplained high ALP levels, radiotherapy with possible effect on bone, hyper caemia, metabolic bone diseases other than osteoporosis) 8.Patients with contraindications to bisphosphonates (severe renal failure, esophageal achalasia, hypocalcemia, hypersensitivity to bisphosphonates) 9. Patients who have received Denosumab subcutaneous injection 60 mg within 6 months of obtaining consent, or Zoledronic Acid Hydrate intravenous solution 5 mg within 1 year of obtaining consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath